Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M James You

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Cell Death & Disease|November 5, 2022
Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemiaChen Tian, Yueyang Li, Lina Wang, et al.
Oncogene|October 31, 2012
DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemiaS Lin, L Tian, H Shen, et al.
Cancer Letters|March 13, 2025
Dependence on Mdm2 for Mdm4 inhibition of p53 activityShunbin Xiong, Yun Zhang, Xin Zhou, et al.
American Journal of Clinical Pathology|April 6, 2021
B-Lymphoblastic Leukemia With Aberrant CD5 ExpressionMatthew T Ye, Jia Zhu, David X Luo, et al.
Oncotarget|March 19, 2016
BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21Hyemin Lee, Fangyan Dai, Li Zhuang, et al.
American Journal of Hematology|August 17, 2024
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemiaQiudan Shen, Elias J Jabbour, Guilin Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2022
LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stageKerri-Ann Latchmansingh, Xiaoqiong Wang, Ramiro E Verdun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2012
TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantationKeyur P Patel, Faisal A Khokhar, Tariq Muzzafar, et al.
Cytotherapy|July 3, 2021
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemiaSijie Lu, Eran Tallis, Xiaoling Ding, et al.
American Journal of Clinical Pathology|September 5, 2024
Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemiaShuyu E, Jie Xu, Sa A Wang, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Cell Death & Disease|November 5, 2022
Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemiaChen Tian, Yueyang Li, Lina Wang, et al.
Oncogene|October 31, 2012
DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemiaS Lin, L Tian, H Shen, et al.
Cancer Letters|March 13, 2025
Dependence on Mdm2 for Mdm4 inhibition of p53 activityShunbin Xiong, Yun Zhang, Xin Zhou, et al.
American Journal of Clinical Pathology|April 6, 2021
B-Lymphoblastic Leukemia With Aberrant CD5 ExpressionMatthew T Ye, Jia Zhu, David X Luo, et al.
Oncotarget|March 19, 2016
BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21Hyemin Lee, Fangyan Dai, Li Zhuang, et al.
American Journal of Hematology|August 17, 2024
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemiaQiudan Shen, Elias J Jabbour, Guilin Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2022
LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stageKerri-Ann Latchmansingh, Xiaoqiong Wang, Ramiro E Verdun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2012
TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantationKeyur P Patel, Faisal A Khokhar, Tariq Muzzafar, et al.
Cytotherapy|July 3, 2021
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemiaSijie Lu, Eran Tallis, Xiaoling Ding, et al.
American Journal of Clinical Pathology|September 5, 2024
Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemiaShuyu E, Jie Xu, Sa A Wang, et al.
Pageof 13